We just had solid news about great trial results on Friday. I'm sure there is plenty more great news coming in time. This gem has been beat up like many other tickers these last few months and I believe bottom was already put in in the $2.30 area. No funding needed to proceed with the next phase of trials. No fear of any dilution and any good news moving forward should continue to spark more buying and higher prices as we move towards potential FDA approvals. IMO
News 
Market Data 
Discover 
